Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer

Abstract

Background. Intravenous ascorbic acid (IV AA) has been used extensively in cancer patients throughout the United States. Currently, there are limited data on the safety and clinical effects of IV AA. The purpose of this study was to expand the current literature using a retrospective analysis of adverse events and symptomatic changes of IV AA in a large sample of cancer patients. Methods. We conducted a retrospective chart review of all patients receiving IV AA for cancer at the Thomas Jefferson University Hospital over a 7-year period. We assessed all reports of adverse events, laboratory findings, and hospital or emergency department admissions. We also reviewed quality-of-life data, including fatigue, nausea, pain, appetite, and mood. Results. There were 86 patients who received a total of 3034 doses of IV AA ranging from 50 to 150g. In all, 32 patients received only ascorbic acid as part of their cancer management (1197 doses), whereas 54 patients received ascorbic acid in conjunction with chemotherapy (1837 doses). The most common adverse events related to ascorbic acid were temporary nausea and discomfort at the injection site. All events reported in the ascorbic acid alone group were associated with less than 3% of the total number of infusions. Patients, overall, reported improvements in fatigue, pain, and mood while receiving ascorbic acid. Conclusions. The results of this retrospective analysis support the growing evidence that IV AA is generally safe and well tolerated in patients with cancer, and may be useful in symptom management and improving quality of life.

The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review

“…In 8 studies, vitamin C was given intravenously (IV), all in different doses and time intervals [22,25,26,27,28,33,35,37]. In 8 studies intravenous vitamin C (IVC) was given followed by or in combination with oral vitamin C supplementation [1,2,23,24,30,31,34,36].…”

“…In 7 studies, conventional anti-cancer treatment was given in addition to the administration of vitamin C [22,24,25,27,34,35,37]. In 6 studies, this was not specifically documented, but it seems unlikely that patients had concomitant treatments [3,26,28,30,32,36] and in 6 articles it was written that no additional treatment was given at the time of the intervention with vitamin C [1,2,23,29,31,33].…”

The effect of vitamin C supplementation on neutropenia induced by cyclophosphamide in mice

“…Vitamin C as an immunomodulatory nutrient with a strong potential against gastrointestinal damage induced by antineoplastic drugs 42 and is also able to contribute to the reduction of symptom severity 43,44 , which could explain gradual weight loss throughout the study.…”

Enhancing the Effect of Pharmacological Ascorbate in Cancer Therapy via Acid‐Triggered Ferritin Nanoparticles

“…Surprisingly, intravenous pharmacological ascorbate is now in wide use by the American public . Extensive literatures and clinical trials revealed that pharmacological ascorbate could be a promising chemotherapeutic drug for cancer patients . Recent clinical trials also showed that it is a potential adjuvant to improve the efficacy of standard cancer therapy in ovarian, brain cancer, and lung cancer patients .…”